SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

NATCO Pharma informs about outcome of board meeting

13 Aug 2021 Evaluate

NATCO Pharma has informed that the Board of Directors of the Company at their meeting held ON 12th August 2021 have considered and approved the following along with other items of business: Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2021 prepared under Indian Accounting Standards (IND-AS) and as per Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended from time to time (‘Listing Regulations’) along with Limited Review Report of the Statutory Auditors. It has enclosed a copy of the same and declared interim dividend of Rs 2 (100%) each per equity share of Rs 2 each for the financial year 2021-22. The date for taking on record of its shareholders eligible for the purpose of payment of interim dividend record date is fixed as Wednesday the 25th day of August, 2021. The payment of said interim dividend will be paid from 31st August 2021. The company is also updating the financial results on the website of the Company. The company has also enclosed press release on Q1 FY 2021-22 results. Meeting commenced at 10.45 am and concluded at 1.00 pm.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

1099.10 -19.85 (-1.77%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×